Skip to main content
. 2021 Mar 22;118(13):e2012748118. doi: 10.1073/pnas.2012748118

Fig. 3.

Fig. 3.

The GLS1 isoform switch confers castration resistance to PCa cells. (A and B) Western blots show KGA and GAC expression of LNCaP and PC3 cells transduced with KGA-specific, GAC-specific, or control shRNAs and the corresponding cell viability for each cell line (n = 3 replicates for two independent experiments). (C and D) Glutamine utilization indicated by the ratio of intracellular glutamate/glutamine of cells in A and B (n = 3 cultures per group). (E and F) Cell viability after knocking out GLS1 and introducing KGA and GAC back, respectively (n = 3 replicates for two independent experiments). (G and H) Enzymatic activity of KGA and GAC as measured by the ratio of intracellular glutamate/glutamine in cells described in E and F (n = 3 cultures per group). (I) Western blot and IHC staining of GAC overexpression in LNCaP cells and the corresponding xenograft tumor. (J) Cell viability of LNCaP cells overexpressing GAC and LNCaP/Vec control in regular medium or charcoal-stripped medium (ADT) (n = 3 replicates for two independent experiments). (K and L) Xenograft tumor growth curves with or without surgical castration (CS) and representative images of tumor size (n = 4 in each group). (M and N) Cell viability of LNCaP/Vec and LNCaP/GAC treated with glutamine (Gln)/glucose (Glc) depletion or supplemented glutamine/glucose in the charcoal-stripped medium (ADT) (n = 3 replicates for two independent experiments). Data are expressed as mean ± SD. *P < 0.05, **P < 0.01, and ***P < 0.001 by two-tailed Student’s t test. n.s., not significant.